News
While precision oncology requires robust biomarkers, current predictors for lung adenocarcinoma (LUAD) often show limited clinical utility. This study investigates the multifaceted roles of ZC3H12D, a ...
Zongertinib conferred a clinically meaningful benefit in patients with previously treated, advanced, HER2-mutant NSCLC in a phase 1 trial.
A study led by the Barcelona Institute for Global Health (ISGlobal), a centre supported by "la Caixa" Foundation, in collaboration with the Clínic-IDIBAPS, has shown for the first time, how lung ...
A study led by the Barcelona Institute for Global Health (ISGlobal) in collaboration with the Clínic-IDIBAPS, has shown, for ...
Lymphomas belong to the group of malignant diseases of the immune system and mainly affect the organs of the lymphatic system ...
This week is Lung Cancer Action Week, and the American Lung Association is raising awareness of lung cancer and encouraging Louisiana residents to take action to help end the disease. Lung cancer is ...
State Key Laboratory of Food Science and Resources, Jiangnan University, Wuxi 214122, China International Joint Laboratory on Food Safety, Jiangnan University, Wuxi 214122, China Institute of ...
The test processes whole-slide images of non-small cell lung cancer tissue to provide a quantitative TROP2 score, which Roche says provides a level of precision beyond manual methods. TROP2 has ...
Raymond Osarogiagbon, MD, discusses the challenges of implementing lung cancer screening guidelines and the need for increased awareness and access. In this clip, Raymond Osarogiagbon, MD ...
Breast cancer that has spread to lymph nodes may be treated more aggressively than localized cancer, because it has a greater potential to travel to other parts of the body. You have thousands of ...
Earlier this year, Mellencamp said doctors discovered several tumors in her brain and lung, which she confirmed were metastases of melanoma and would be treated with surgery and immunotherapy.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results